Based on 2 analysts offering 12 month price targets for Nervgen Pharma Corp
Min Forecast
$10.00+484.8%
Avg Forecast
$12.50+630.99%
Max Forecast
$15.00+777.19%
Should I buy or sell NGEN stock?
Based on 2 analysts offering ratings for Nervgen Pharma Corp.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NGEN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates NGEN as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -12.86% per year. Learn More
Be the first to know when Wall Street analysts revise their NGEN stock forecasts and price targets.
Is Nervgen Pharma Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: NGEN) stock is to Buy NGEN stock.
Out of 2 analysts, 0 (0%) are recommending NGEN as a Strong Buy, 2 (100%) are recommending NGEN as a Buy, 0 (0%) are recommending NGEN as a Hold, 0 (0%) are recommending NGEN as a Sell, and 0 (0%) are recommending NGEN as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year NGEN price target, the average NGEN price target is $12.50, with the highest NGEN stock price forecast at $15.00 and the lowest NGEN stock price forecast at $10.00.
On average, Wall Street analysts predict that Nervgen Pharma's share price could reach $12.50 by Jul 14, 2027. The average Nervgen Pharma stock price prediction forecasts a potential upside of 630.99% from the current NGEN share price of $1.71.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.